Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 0.50 |
| ▸ | HTT | P42858 | 10/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | NPC1 | O15118 | 6/20 | 0.50 |
| ▸ | MITF | O75030 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 8/20 | 0.48 |
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.48 |
| ▸ | GALR3 | O60755 | 1/20 | 0.48 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.48 |
| ▸ | GPR183 | P32249 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3845405 | 0.82 | SMN1; SMN2 (0.43) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL17738012 | 0.82 | SMN1; SMN2 (0.50) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL9372342 | 0.82 | HTT (0.49) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL19738690 | 0.82 | HTT (0.49) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL27619400 | 0.81 | SMN1; SMN2 (0.46) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL11272569 | 0.81 | SMN1; SMN2 (0.46) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL1627207 | 0.81 | SMN1; SMN2 (0.46) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL3847199 | 0.81 | SMN1; SMN2 (0.46) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL8545976 | 0.79 | SMN1; SMN2 (0.39) | SMN1; SMN2HTTALDH1A1NPC1MITF | |
| SCHEMBL19738637 | 0.79 | HTT (0.47) | SMN1; SMN2HTTALDH1A1NPC1MITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0169375-B1 | PROCESS FOR PRODUCING 2-TERT.-BUTYL-4,5-DICHLORO-3(2H)-PYRIDAZINONE | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1989-12-20 | — | — | EP | claimed |
| EP-0169375-A2 | Process for producing 2-tert.-butyl-4,5-dichloro-3(2H)-pyridazinone | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-01-29 | — | — | EP | claimed |
| JP-5294942-A | — | — | None | — | — | JP | disclosed |
| JP-1213280-A | — | — | None | — | — | JP | disclosed |
| JP-61010560-A | — | — | None | — | — | JP | disclosed |
| JP-61010561-A | — | — | None | — | — | JP | disclosed |
| JP-61109777-A | — | — | None | — | — | JP | disclosed |
| JP-61112058-A | — | — | None | — | — | JP | disclosed |
| JP-61097270-A | — | — | None | — | — | JP | disclosed |
| US-20250242063-A1 | METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-07-31 | — | — | US | disclosed |
| CN-120136791-A | Pyridaben intermediate II New synthesis process of chloropyridazinone | 河北优农派生物科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| JP-S6197270-A | PRODUCTION OF PYRIDAZINONE DERIVATIVE | NISSAN CHEM IND LTD | 1986-05-15 | — | — | JP | disclosed |
| EP-0169375-A2 | Process for producing 2-tert.-butyl-4,5-dichloro-3(2H)-pyridazinone | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-01-29 | — | — | EP | disclosed |
| EP-0169375-A2 | Process for producing 2-tert.-butyl-4,5-dichloro-3(2H)-pyridazinone | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-01-29 | — | — | EP | disclosed |
| EP-0169375-A2 | Process for producing 2-tert.-butyl-4,5-dichloro-3(2H)-pyridazinone | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-01-29 | — | — | EP | disclosed |
| JP-S6110560-A | PREPARATION OF 2-TERTIARY-BUTYL-4,5-DICHLORO-3(2H)-PYRIDAZINONE | NISSAN CHEM IND LTD | 1986-01-18 | — | — | JP | disclosed |
| JP-S6110561-A | PREPARATION OF 2-TERTIARY-BUTYL-4,5-DICHLORO-3(2H)-PYRIDAZINONE | NISSAN CHEM IND LTD | 1986-01-18 | — | — | JP | disclosed |
| EP-0134439-A1 | Pyridazinone derivatives, preparation thereof and insecticidal, acaricidal, fungicidal compositions | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1985-03-20 | — | — | EP | disclosed |
| US-4366155-A | 1-Benzoyl-3-(6-oxopyridazinyl)ureas, compositions, and insecticidal method | ELI LILLY AND COMPANY (US) | 1982-12-28 | — | — | US | disclosed |
| EP-0063413-A1 | 1-Benzoyl-3-(heterocyclic)ureas, compositions, and insecticidal method | ELI LILLY AND COMPANY (US) | 1982-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250242063-A1 | METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF | TNNI3, FABP3, MPI | SMN1; SMN2 2628/4885HTT 4436/4885ALDH1A1 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.